Health Policy and Intelligence Institute

Practical insights on regulatory and policy developments in health industries

Featured - 4 items

Regulatory alerts

Stay in the know: Unraveling the latest health industry regulations

President-elect Donald Trump’s healthcare agenda

Policy insights on deregulation, healthcare access and security

IRA drug price negotiation Maximum Fair Price

What this means to pharmaceutical organization and payers

AI in the health industry

The evolving risk and regulatory landscape

As regulatory requirements evolve in the health industry, PwC’s Health Policy and Intelligence Institute helps drive proactive decision making where it matters most. The institute brings together risk and regulatory professionals and subject matter specialists to analyze the latest developments and offer guidance on what to expect, where uncertainty lies and where regulations are headed next.

Stay up to date on the latest insights by subscribing through the PwC's Preference Center below (select Health Policy and Intelligence Institute under Featured Insights).

Get started with PwC's preference center

Our insights. Your choices.

Contact us

Kelly Griffin, PhD, RAC

Director, Health Policy and Intelligence Institute, PwC US

Tiffany Gallagher

Principal, Health Industries, Cyber, Risk & Regulatory Leader, PwC US

Dave Merriam

Partner, Health Services, Cyber, Risk & Regulatory Sector Leader, PwC US

Brian Riewerts

Principal, Pharmaceutical and Life Sciences, Cyber, Risk and Regulatory Leader, PwC US

Audit and Assurance services Consulting Tax services Newsroom Alumni US offices Contact us

© 2017 - 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.